Clinical therapeutics | 2021

Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery.

 
 
 
 
 

Abstract


PURPOSE\nThe aim of this study is to prospectively investigate the influence of ADRB and COMT gene polymorphisms on postoperative outcomes of patients undergoing cardiac surgery.\n\n\nMETHODS\nThis prospective cohort study included 223 patients undergoing elective cardiac valve surgery using cardiopulmonary bypass. Demographic information, intraoperative data, postoperative data, and blood samples were collected. Patients were genotyped for single-nucleotide polymorphisms (SNPs) of ADRB1 rs1801253, ADRB2 rs1042713, and COMT rs4680. Major adverse cardiovascular and cerebrovascular events (MACCEs) were used as the primary outcome to evaluate the postoperative prognosis of patients. Secondary outcomes included the duration of mechanical ventilatory support, intensive care unit stay, postoperative hospital stay, and postoperative need of inotropic or vasoactive agents.\n\n\nFINDINGS\nThe overall incidence of MACCEs was 15.2%. Among 3 SNP loci, only different genotyped carriers of ADRB2 rs1042713 had statistically significant differences in the incidence of MACCEs (P\xa0=\xa00.005), especially for acute kidney injury (P\xa0=\xa00.023). The proportions of postoperative norepinephrine demand of patients carrying the AA genotype of ADRB2 rs1042713 (P\xa0=\xa00.016) and the AG genotype of COMT rs4680 (P\xa0=\xa00.018) were low. The duration of mechanical ventilatory support (P\xa0=\xa00.034) and postoperative hospital stay (P\xa0=\xa00.045) of patients carrying the AG genotype of COMT rs4680 was shortest. After multiple logistic regression analysis, we found that the G allele carriers of ADRB2 rs1042713 had a higher risk of MACCEs (AG vs AA genotype: odds ratio [OR]\xa0=\xa04.348; 95% CI, 1.529-12.359, P\xa0=\xa00.006; GG vs AA genotype: OR\xa0=\xa03.722; 95% CI, 1.060-13.071; P\xa0=\xa00.040), in particular with acute kidney injury (AG vs AA genotype: OR\xa0=\xa05.273; 95% CI, 1.093-25.451; P\xa0=\xa00.038; GG vs AA genotype: OR\xa0=\xa07.533; 95% CI, 1.275-44.522; P\xa0=\xa00.026). There was no SNP-SNP interaction found among the 3 SNPs with multifactor dimensionality reduction analysis.\n\n\nIMPLICATION\nThe ADRB2 rs1042713 polymorphism might be related to prognosis of patients undergoing cardiac surgery. Patients carrying the G allele of ADRB2 rs1042713 had a higher risk of developing MACCEs, especially acute kidney injury. chictr.org.com identifier: ChiCTR1800015105.

Volume None
Pages None
DOI 10.1016/j.clinthera.2020.12.010
Language English
Journal Clinical therapeutics

Full Text